LUYAO

Luye Pharma is a China-founded, Hong Kong-listed international pharmaceutical company focused on the research, development, manufacturing, and commercialization of innovative medicines. The company operates across central nervous system, oncology, cardiovascular, metabolism, and related therapeutic areas, with a portfolio of more than 30 marketed products and a broad late-stage pipeline. Luye is particularly known for advanced drug-delivery technologies such as microspheres, liposomes, and transdermal systems, and it has expanded into biologics through its Boan Biotech subsidiary. The group sells products in more than 80 countries and regions and maintains R&D operations in China, the United States, and Europe. Its business model combines internal R&D, global manufacturing, and international commercialization with selected partnerships and licensing arrangements.